AbbVie Inc.

ABBV· NYQ· Healthcare· Drug Manufacturers - General

$266.54

+0.83% Delayed prices.

AbbVie Inc. (ABBV) quarterly earnings

From the Sep 26, 2026 report · Read the full report

Next earnings
Oct 29, 2026

EPS: actual vs expected

Beat estimates in 3 of the last 4 quarters.

QuarterExpectedActualSurprise
Jun 30, 20263.613.65+1.2%
Mar 31, 20262.672.65-0.8%
Dec 31, 20252.652.71+2.2%
Sep 30, 20251.781.86+4.2%

Recent quarters

QuarterRevenueNet incomeDiluted EPS
Jun 30, 202616.99B3.61B2.03
Mar 31, 202615B695M0.39
Dec 31, 202516.62B1.82B1.02
Sep 30, 202515.78B186M0.1
Jun 30, 202515.42B938M0.52

Analysts' estimates

Diluted EPSEPS (low - high)RevenueGrowth
Current quarter3.843.77 - 3.8717.31B+9.7%
Next quarter3.863.77 - 3.9818.32B+10.2%
Current fiscal year14.0113.9 - 14.1267.6B+10.5%
Next fiscal year16.2615.13 - 17.5973.5B+8.7%

Frequently asked questions

When does ABBV report earnings?

AbbVie Inc. (ABBV) is expected to report its next results on Oct 29, 2026.

Does ABBV usually beat estimates?

Beat estimates in 3 of the last 4 quarters.

Data as of Sep 29, 2026. Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.

By subscribing you accept the privacy policy. You can unsubscribe at any time.